SCHEMBL6978045

SCHEMBL6978045

CCOC(=O)CNN(c1cccc2c1N(C(=O)CCc1ccc(C#N)cc1)CCC2)S(=O)(=O)Cc1ccccc1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.35
LMNA P02545 1/20 0.35
MAPT P10636 3/20 0.35
YAP1 P46937 1/20 0.35
L3MBTL1 Q9Y468 2/20 0.35
RORC P51449 1/20 0.34
NOTUM Q6P988 1/20 0.33
USP14 P54578 1/20 0.32
DPP8 Q6V1X1 1/20 0.32
DPP9 Q86TI2 1/20 0.32
GAA P10253 1/20 0.32
CNR2 P34972 1/20 0.32
NPC1 O15118 1/20 0.32
MAPK1 P28482 1/20 0.32
RAB9A P51151 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
AVPR2 P30518 1/20 0.32
PTGER4 P35408 1/20 0.32
NR3C1 P04150 1/20 0.32
AR P10275 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6978042 0.86 NR3C1 (0.42) ALDH1A1LMNAMAPTYAP1L3MBTL1
SCHEMBL6987767 0.83 TP53 (0.42) ALDH1A1LMNAL3MBTL1GAANR3C1
SCHEMBL6982692 0.82 L3MBTL1 (0.38) ALDH1A1LMNAMAPTYAP1L3MBTL1
SCHEMBL6980758 0.81 NOTUM (0.42) ALDH1A1LMNAMAPTL3MBTL1NOTUM
SCHEMBL6986000 0.80 NR3C1 (0.36) ALDH1A1LMNAMAPTL3MBTL1NOTUM
SCHEMBL6985399 0.80 NOTUM (0.36) ALDH1A1LMNAMAPTYAP1L3MBTL1
SCHEMBL6976287 0.80 NOTUM (0.38) ALDH1A1MAPTYAP1L3MBTL1NOTUM
SCHEMBL6977636 0.79 ALDH1A1 (0.42) ALDH1A1LMNAMAPTGAANPC1
SCHEMBL6985613 0.78 CCR5 (0.37) ALDH1A1LMNAMAPTYAP1L3MBTL1
SCHEMBL6987632 0.78 ALDH1A1 (0.39) ALDH1A1LMNAMAPTRORCNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0991624-B1 PHENYLALKYL DERIVATIVES WITH THROMBIN-INHIBITING EFFECT BOEHRINGER INGELHEIM PHARMA (DE) 2003-11-19 EP disclosed